cost-effectiveness of preoperative screening and eradication of staphylococcus aureus carriage成本效益的术前检查和消除金黄色葡萄球菌马车.pdfVIP

cost-effectiveness of preoperative screening and eradication of staphylococcus aureus carriage成本效益的术前检查和消除金黄色葡萄球菌马车.pdf

  1. 1、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
cost-effectiveness of preoperative screening and eradication of staphylococcus aureus carriage成本效益的术前检查和消除金黄色葡萄球菌马车

Cost-Effectiveness of Preoperative Screening and Eradication of Staphylococcus aureus Carriage Marjan W. M. Wassenberg1,2, G. Ardine de Wit3,4, Marc J. M. Bonten1,3* 1 Department of Medical Microbiology, University Medical Center, Utrecht, The Netherlands, 2 Department of Internal Medicine and Infectious Diseases, University Medical Center, Utrecht, the Netherlands, 3 Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands, 4 National Institute of Public Health and the Environment, Bilthoven, The Netherlands Abstract Background: Preoperative screening for nasal S. aureus carriage, followed by eradication treatment of identified carriers with nasal mupirocine ointment and chlorhexidine soap was highly effective in preventing deep-seated S. aureus infections. It is unknown how cost-effectiveness of this intervention is affected by suboptimal S. aureus screening. We determined cost- effectiveness of different preoperative S. aureus screening regimes. Methods: We compared different screening scenarios (ranging from treating all patients without screening to treating only identified S. aureus carriers) to the base case scenario without any screening and treatment. Screening and treatment costs as well as costs and mortality due to deep-seated S. aureus infection were derived from hospital databases and prospectively collected data, respectively. Results: As compared to the base case scenario, all scenarios are associated with improved health care outcomes at reduced costs. Treating all patients without screening is most cost-beneficial, saving J7339 per life year gained, as compared to J3330 when only identified carriers are treated. In sensitivity analysis, outcomes are susceptible to the sensitivity of the screening test and the efficacy of treatment. Redu

您可能关注的文档

文档评论(0)

xyz118 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档